About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 44700 record(s)
Req # A-2023-001606
The most recent Module 2.3: Quality Overall Summary (QOS) submitted the sponsor for the Semaglutide Abbreviated New Drug Submission (ANDS).Organization: Health Canada
September 2024
Req # A-2024-000126
In respect of the second, newest Abbreviated New Drug Submission (ANDS) for semaglutide (the Second Semaglutide ANDS), provide a copy of the ANDS cover letter of the company (sponsor) who submitted the Second Semaglutide ANDS.Organization: Health Canada
September 2024
Req # A-2024-000256
The labels for all package types for all strengths or combinations of strengths of the final dosage forms which were included in the initial filing of the Abbreviated New Drug Submission (ANDS) for Tolvaptan from which was accepted into review in…Organization: Health Canada
September 2024
Req # A-2024-000266
All correspondence and other records relating to any pre-submission meeting(s) requested by the sponsor of the Degarelix Abbreviated Drug Submission (ANDS), and any pre-submission inquir(y/ies) submitted by the sponsor of the Degarelix ANDS.Organization: Health Canada
September 2024
Req # A-2024-000342
All Medical Device Incident Reports received by Health Canada pertaining to breast implants manufactured by Sientra/Clarion Medical Technologies and sold in Canada.Organization: Health Canada
September 2024
Req # A-2024-000366
All emails and associated attachments corresponding to the leadup, request for, and ultimately deemed-unnecessary Issue Analysis Summary (IAS) that is referred to in the Inquiry of Ministry question number Q-2670 (2 May 2024) by Member of Parliament…Organization: Health Canada
September 2024
Req # A-2018-001235
Obtain letters/correspondence sent and received by the Minister in relation to marijuana from its legalization on October 17, 2018, to December 1, 2018.Organization: Health Canada
September 2024
Req # A-2024-00089
A copy of documents pertaining to the Governor-in-Council appointment process for the Manitoba vacancy on the Historic Sites and Monuments Board of CanadaOrganization: Historic Sites and Monuments Board of Canada
September 2024
Req # A-2024-00839
All rejected decisions from Refugee Protection Division and Refugee Appeal Division. From all regions, where the counsels on file were Usman Mahmood, B.P.S Mangat, Said Iqbal. Timeline for the request is 10 January 2022 to 31 August 2024. I want PDF…Organization: Immigration and Refugee Board of Canada
September 2024
Req # A-2024-00768
Please provide redacted electronic copies of the written reasons for the following RPD decisions: TC3-16048; TC3-26844; TC3-32633; TC3-36077; TC3-38011; VC2-09284; VC3-02922; VC3-05627; VC3-07641; TC3-37312; TC2-28915; TC3-12392; TC2-07046; VC1-…Organization: Immigration and Refugee Board of Canada
September 2024